This webcast recording reviews the most salient global regulatory changes in 2020 for Medical Devices and Diagnostics and how they impact the Asia Pacific. Brandwood CKC's TJ Thiel and John Lockwood of Pearl Pathways, delve into the major regulatory bodies' most important regulatory changes and analyse the potential impacts on the Asia Pacific. There is also a focus on changes in Australia's TGA, Japan's PMDA, and China's NMPA. Additionally, this presentation takes into account the impact the COVID-19 pandemic has had and how regulators have adapted regulatory changes to meet medical supply demand. The presentation and Q&A were pre-recorded during a RAPS (Regulatory Affairs Professional Society) US Chapter program.

Podden och tillhörande omslagsbild på den här sidan tillhör Brandwood CKC. Innehållet i podden är skapat av Brandwood CKC och inte av, eller tillsammans med, Poddtoppen.